Cipher Pharmaceuticals completes Canadian distribution and supply agreement for extended-release tramadol CIPHER PHARMACEUTICALS DND 9/26/2011 8:30:00 AM...
Read more
Moviprep® Launched in Canada

Norgine and Medical Futures are pleased to announce the launch of MOVIPREP®, a bowel cleansing preparation in Canada. “The launch of MOVIPREP® underlines Medical Futures’ commitment to the prevention and treatment of gastrointestinal diseases,” said Colin Campbell, Medical Futures’ CEO. Commenting on the launch Peter Stein, Norgine’s...
Read more
Medical Futures Inc. announces NEW General Manager

Medical Futures Inc. would like to announce the newest addition to the Medical Futures Inc. team. Colin Campbell will be joining MFI as the new General Manager. Colin brings over 20 years’ experience as a senior financial and operations executive in the pharmaceutical and biotech industries, including start-up, global...
Read more
Medical Futures Inc. partners with Ardeypharm GmbH for Mutaflor® in Canada and the U.S.A

Ardeypharm GmbH, Herdecke, Germany and Medical Futures Inc (MFI), Canada/USA, recently entered a license agreement for MFI to market Mutaflor® in Canada and USA. Mutaflor® is a probiotic treatment for preventing and/or maintaining remission of ulcerative colitis and for chronic constipation. Under the license Ardeypharm will supply the product while...
Read more
Medical Futures partners with Norgine for Moviprep® in Canada

Norgine, the leading European specialty pharmaceutical company, has today announced that it has granted Medical Futures the exclusive rights to market MOVIPREP® in Canada. MOVIPREP is a novel patent-protected product developed by Norgine for bowel cleansing prior to colonoscopy and other situations where a clean bowel is required. The...
Read more
